COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab - 22/07/20
Doi : 10.1016/j.jaci.2020.05.005
Ulrike Förster-Ruhrmann, MD, PhD a, Agnieszka J. Szczepek, MSc, PhD a, Claus Bachert, MD, PhD b, Heidi Olze, MD, PhD a 
a Department of Otorhinolaryngology, Head and Neck Surgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
b Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Ghent, Belgium, Germany
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 146 - N° 1
P. 218 - Luglio 2020 Ritorno al numero
Articolo precedente
- Complement activation in patients with COVID-19: A novel therapeutic target
- Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, Mauro Panigada, Stefano Aliberti, Francesco Blasi, Francesco Tedesco, Flora Peyvandi
- Serum folate metabolites, asthma, and lung function in a nationwide US study
- Yueh-Ying Han, Erick Forno, Franziska Rosser, Juan C. Celedón
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.